Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COVID-19 on patients with immune-mediated rheumatic disease: a comparative study of disease activity, fatigue, and psychological distress over six months.
Marques C, Pinheiro MM, Lopes J, Ribeiro SLE, de Castro MVM, de Azevedo Valadares LD, Ranzolin A, de Andrade NPB, do Espírito Santo RC, Araújo NC, Vieira CM, Valim V, Santos FPST, da Rocha LF Jr, Kakehasi AM, Reis APMG, Dos Reis-Neto ET, Pileggi GS, Ferreira GA, da Mota LMH, Monticielo O, Xavier RM. Marques C, et al. Among authors: pileggi gs. Adv Rheumatol. 2025 Jan 22;65(1):4. doi: 10.1186/s42358-025-00434-x. Adv Rheumatol. 2025. PMID: 39844312
Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER Cohort.
Machado KLLL, Burian APN, Martins-Filho OA, Mill JG, Ferreira LB, Tapia KRL, Moulin ACS, Moulaz IR, Ribeiro PDC, Magalhães VO, Biegelmeyer E, Peixoto FMMMC, Ribeiro SLE, Telles CMPF, Bühring J, Sartorio NS, Hax V, Rezende RPV, Baptista KL, Melo AKG, Cruz VA, Vieira RMRA, Azevedo RH, Azevedo VF, Pinheiro MM, Monticielo OA, Reis Neto ETD, Teixeira-Carvalho A, Xavier RM, Sato EI, de Souza VA, Ferreira GA, Pileggi GS, Valim V. Machado KLLL, et al. Among authors: pileggi gs. Vaccines (Basel). 2024 Dec 3;12(12):1367. doi: 10.3390/vaccines12121367. Vaccines (Basel). 2024. PMID: 39772029 Free PMC article.
Socioeconomic factors and COVID-19 mortality in immune-mediated rheumatic diseases patients: regional analysis from Argentina, Mexico and Brazil.
Martinez-Martinez MU, Isnardi CA, Alpizar-Rodriguez D, Pons-Estel GJ, Virasoro BM, Alfaro MA, Petkovic I, Quintana R, Berbotto G, Salinas MJH, Ornella S, Pera M, Colunga-Pedraza IJ, Irazoque-Palazuelos F, Reyes-Cordero G, Rodriguez-Reyna TS, Veloz-Aranda JA, Skinner-Taylor CM, Juárez-Mora IM, Silveira LH, Marques CDL, Xavier RM, Kakehasi AM, Gomides AP, Dos Reis-Neto ET, Pileggi GS, Ferreira GA, da Mota LMH, Pinheiro MM, Calderaro DC. Martinez-Martinez MU, et al. Among authors: pileggi gs. Adv Rheumatol. 2024 Oct 9;64(1):78. doi: 10.1186/s42358-024-00418-3. Adv Rheumatol. 2024. PMID: 39385233
Predictors of Hospitalization in Breakthrough COVID-19 among Fully Vaccinated Individuals with Immune-Mediated Rheumatic Diseases: Data from SAFER-Study.
Calderaro DC, Valim V, Ferreira GA, Machado KLLL, Ribeiro PDC, Ribeiro SLE, Sartori NS, de Rezende RPV, de Melo AKG, Cruz VA, Vieira ASR, Kakehasi AM, de Landa AT, Burian APN, Peixoto FMMMC, Telles CMPF, do Espírito Santo RC, Baptista KL, de Oliveira YGP, Magalhães VO, de Lima RL, Biegelmeyer E, Lorencini PZ, Teixeira-Carvalho A, Dos Reis-Neto ET, Sato EI, Pinheiro MM, Monticielo OA, de Souza VA, Xavier RM, Pileggi GS; SAFER-Study Group Task Force. Calderaro DC, et al. Among authors: pileggi gs. Vaccines (Basel). 2024 Sep 9;12(9):1031. doi: 10.3390/vaccines12091031. Vaccines (Basel). 2024. PMID: 39340061 Free PMC article.
In Silico Approach to Model Heat Distribution of Magnetic Hyperthermia in the Tumoral and Healthy Vascular Network Using Tumor-on-a-Chip to Evaluate Effective Therapy.
Munoz JM, Pileggi GF, Nucci MP, Alves ADH, Pedrini F, Valle NMED, Mamani JB, Oliveira FA, Lopes AT, Carreño MNP, Gamarra LF. Munoz JM, et al. Among authors: pileggi gf. Pharmaceutics. 2024 Aug 31;16(9):1156. doi: 10.3390/pharmaceutics16091156. Pharmaceutics. 2024. PMID: 39339193 Free PMC article.
Safety of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with rheumatoid arthritis: data from the Brazilian multicentric study safer.
Cruz VA, Guimarães C, Rêgo J, Machado KLLL, Miyamoto ST, Burian APN, Dias LH, Pretti FZ, Batista DCFA, Mill JG, de Oliveira YGP, Gadelha CSE, da Penha Gomes Gouveia M, Moulin ACS, Souza BO, Aguiar LGR, Vieira GSS, Grillo LL, de Lima MD, Pasti LP, Surlo HF, Faé F, Moulaz IR, Macabú MO, Ribeiro PDC, Magalhães VO, de Aguiar MF, Biegelmeyer E, Peixoto FMMMC, Kayser C, de Souza AWS, de Moura Castro CH, Ribeiro SLE, Telles CMPF, Bühring J, de Lima RL, Dos Santos SHO, Dias SEB, de Melo NS, da Silva Sanches RH, Boechat AL, Sartori NS, Hax V, Dória LD, de Rezende RPV, Baptista KL, Fortes NRQ, de Melo AKG, Melo TS, de Abreu Vieira RMR, Vieira ASR, Kakehasi AM, Tavares ACFMG, de Landa AT, da Costa PVT, Azevedo VF, Martins-Filho OA, Peruhype-Magalhães V, de Medeiros Pinheiro M, Monticielo OA, Dos Reis-Neto ET, Ferreira GA, de Souza VA, Teixeira-Carvalho A, Xavier RM, Sato EI, Valim V, Pileggi GS, da Silva NA. Cruz VA, et al. Among authors: pileggi gs. Adv Rheumatol. 2024 Aug 12;64(1):58. doi: 10.1186/s42358-024-00397-5. Adv Rheumatol. 2024. PMID: 39135131 Clinical Trial.
64 results